Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 0.80%, near the low end of its 5-year range (0.00%–4.04%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
0.27%
DEBT TO ASSETS RATIO AVG 5Y
0.80%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 526 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Clover Health Investments, Corp.
Market Cap
$2.43B
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
0.27%
5Y Avg
0.80%
Market Cap
$2.45B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.32B
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.32B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.57B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.18B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.14B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.69B
Debt to Assets Ratio
0.46%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. (CLOV) | $2.43B | 0.00% | 0.00% | 0.27% | 0.80% |
| Liquidia Corporation (LQDA)vs › | $2.45B | 0.25% | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.46B | 0.08% | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.32B | 0.30% | N/A | N/A | N/A |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.32B | 0.11% | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.57B | 0.05% | N/A | N/A | N/A |
| Fortrea Holdings Inc. (FTRE)vs › | $2.18B | 0.41% | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.14B | 0.01% | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 0.46% | N/A | N/A | N/A |
| Addus HomeCare Corporation (ADUS)vs › | $2.12B | 0.07% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
1.50
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.56% |
| 2024-06-30 | 0.59% |
| 2024-03-31 | 0.65% |
| 2023-12-31 | 0.82% |
| 2023-09-30 | 0.47% |
| 2023-06-30 | 0.43% |
| 2023-03-31 | 0.40% |
| 2022-12-31 | 0.72% |
| 2022-09-30 | 1.68% |
| 2022-06-30 | 1.29% |
| 2022-03-31 | 4.04% |
| 2021-12-31 | 2.93% |
| 2021-09-30 | 2.99% |
| 2021-06-30 | 2.40% |
| 2021-03-31 | 6.45% |
| 2020-12-31 | 51.77% |
| 2020-09-30 | 29.45% |
| 2020-06-30 | 21.47% |
| 2019-12-31 | 0.00% |
